Finance

Results: 26221-26232 of 40560

PR Newswire associated0

Hygenco Green Energies with JICA support has finalised MOU with Mitsubishi Power for Green Hydrogen/Ammonia-Fired GTCC Power Plants

PR Newswire associated0

Queclink Debuts GV850: The Future of Programmable IoT and Self-Customizable Solutions

Capital.com And Newsquawk Forge Strategic Partnership To Empower Retail Traders With Real-Time News Feeds

The Nichi BRITE Beta 1,3-1,6 Glucan is produced as an exo-polysaccharide by Aureobasidium Pullulans in a GMP certified facility in Japan and is water soluble. The subjects of Nichi BRITE group in the study were given 250mg Beta glucan as an active ingredient per day for 22 days as an adjuvant, while control group had a placebo instead; both groups were given standard of care treatment. The quantity consumed during the study by each patient is equivalent to four boxes of Nichi BRITE, which comes in a box of 24 sachets, 1.5-gram granule as content with 63 mg active beta glucan as ingredient per sachet. Oral administration was undertaken when possible, and when it was not possible, administration was through feeding gastrostomy or nasogastric tube. No adverse reactions were observed. The efficacy in terms of immune enhancement, cancer biomarker reduction and longer mean survival were reported with Nichi Brite as an adjuvant. (Graphic: Business Wire)

Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer; Encouraging clinical results reported by Chikamori Hospital, Japan.

NORDEN reports net profit of USD 46 million in Q2 2024 and continue to return cash to shareholders

PR Newswire associated0

CAXTON TRAVEL CARD TRAVEL HACKS: EXPERT TIPS

PR Newswire associated0

Stockalzi Elevates Trading Experience with Comprehensive Market Access and Advanced Tools

PR Newswire associated0

Finatechs Launches Revolutionary Trading Platform to Empower Global Traders

PR Newswire associated0

Build-A-Bear Fast Tracks Halloween Collection Due to Viral Leak of New Products

Medscape Global Launches the Affinity™ Platform: Offering Behavioural Insights from Over 13 Million Healthcare Professionals

Oliver Bäte, Chief Executive Officer of Allianz SE (Photo: Allianz SE)

Allianz Achieves Record Profits in First Half 2024

PR Newswire associated0

dsm-firmenich concludes new €1.8 billion Revolving Credit Facility